Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1445556576
总结
CYP2D6 poor metabolizers and intermediate metabolizers are not associated with decreased event-free survival or overall survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizers.